SCNI
Scinai Immunotherapeutics
SCNI
SCNI
18 hedge funds and large institutions have $1.08M invested in Scinai Immunotherapeutics in 2021 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
1 | +$121K | |
2 | +$111K | |
3 | +$103K | |
4 |
VF
Virtu Financial
New York
|
+$70K |
5 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$46K |
Top Sellers
1 | -$120K | |
2 | -$76K | |
3 | -$73K | |
4 |
Wells Fargo
San Francisco,
California
|
-$2.67K |